Journal scan

HPV vaccine reduces cervical pre-cancers in young women

Greater than expected reduction rate in all grades of invasive cervical cancer among women aged 15 to 19 years old 

Screening guidelines and practices, which are undertaken as part of the overall cervical cancer prevention programme, may need to be reviewed as the population of women participating in human papillomavirus (HPV) vaccination increases, according to this study from New Mexico, US.

In this population-based registry study, reported data of women undergoing cytologic and HPV testing and histopathologic examination of cervical intraepithelial neoplasia (CIN), as part of the clinical cervical screening process, was scrutinised.

HPV-immunisation programme

The researchers were examining for trends in the prevalence of CIN, when adjusting for practices that corresponded with the instigation and implementation of the HPV-immunisation programme.

The findings revealed a greater than expected, and significant, reduction in the rate of all grades of invasive cervical cancer among women aged 15


Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Primary Health Care
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?